NRX Pharmaceuticals vs Vistagen Therapeutics
NRXP and VTGN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NRXP and VTGN compare
NRX Pharmaceuticals is the larger company, worth 12 times as much as Vistagen Therapeutics ($94.8M against $8.0M).
NRX Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of −692% compared with −2475% at Vistagen Therapeutics.
Vistagen Therapeutics scores higher on the StockData Score (9 against 0 for NRX Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NRXP | VTGN |
|---|---|---|
| Size and price | ||
| Market cap | $94.8M | $8.0M |
| Share price | $2.19 | $0.180 |
| Change, 1 year | −17.0% | −95.6% |
| Change, 5 years | −95.7% | −99.7% |
| Beta (5Y) | 1.05 | 1.31 |
| Employees | 29 | 41 |
| StockData Score | ||
| Total score | 0 | 9 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 1 (better) |
| Health score | 0 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 27.9× | 3.4× (better) |
| P/B | – | 0.5× |
| Fair value | – | $0.660 |
| Margin of safety | – | 72.7% |
| Growth | ||
| Revenue growth, 5Y average | – | 3.1% |
| Profitability | ||
| Gross margin | 46.6% | – |
| Operating margin | −586% (better) | −2542% |
| Net margin | −692% (better) | −2475% |
| Return on equity | – | −145% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −17.4× | – |
| Current ratio | 0.86 | 2.64 (better) |
| Altman Z-score | −13.64 (better) | −37.10 |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 26.9% | 26.5% |
| Held by insiders | 15.6% | 0.52% |
| Short interest, % of float | 28.6% | 5.6% |
Go deeper
- NRXP stock overview
- NRXP income statement
- NRXP valuation and score
- VTGN stock overview
- VTGN income statement
- VTGN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.